Leblond, V., Morel, P., Dilhuidy, M., Leleu, X., Soussain, C., Leprête, S., Dreyfus, B., Dartigeas, C., Mahé, B., Anglaret, B., Pégourié, B., Besson, C., Aurran, T., Vekhoff, A., Tournilhac, O., Banos, A., Oya, H., Lejeune, J., Ouzegdouh, M., Chevret, S., & , (2017). a phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone. Leukemia & lymphoma, 58(11), 2615–2623. http://access.bl.uk/ark:/81055/vdc_100047676210.0x000028